Tibial Fracture

4

Review clinical trials related to Tibial Fracture. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures

This is a prospective, multicenter, randomized, controlled, non-inferiority clinical trial designed to evaluate the safety and effectiveness of the magnesium-titanium hybrid intramedullary nail system compared with the marketed metal locked intramedullary nail in the treatment of long bone fractures of the extremities.

Participants needed: 160
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: HuaMg Perfection Med Tech (Suzhou) Co., Ltd.Updated: May 6, 2026Locations: 5
Eligibility criteria

Aged ≥ 18 years and ≤ 80 years (inclusive), with skeletal maturity, regardless o... [+3]

Pregnant or lactating women, or individuals with family planning during the stud... [+15]

Status: Not yet recruiting

Assessment of the Verus Frame in Tibial Intramedullary Nailing

This prospective, single-arm Post-Market Clinical Follow-Up (PMCF) study, utilizing a registry-based control group, will assess the Verus frame's effectiveness in achieving precise tibial rotation and alignment during intramedullary nailing procedure, as well as safety of the device. The results will be compared to AO-approved criteria to ensure comprehensive evaluation of its new benefits, regulatory compliance, and continued clinical use. Tibial intramedullary nailing is the gold standard for tibial fracture fixation, where accurate alignment and rotation are crucial for optimal recovery and long-term outcomes.

Participants needed: 25
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Hemitec Finland OyUpdated: Jan 23, 2026Locations: 1
Eligibility criteria

Tibial fracture to be operated by suprapatellar intramedullary nailing technique [+2]

Situations where intramedullary fixation is otherwise contraindicated, e.g., act... [+4]

Status: Recruiting

Tibial IMN Vs. Tibial Micromotion IMN

Our null hypothesis is that micromotion tibial intramedullary fixation (IMFN) does not impact union or complication rates when compared to standard of care treatment with non-micromotion tibial nail fixation. There are no current or past randomized controlled trials comparing these fixation techniques to one another. There is good data supporting both the use of intramedullary fixation for tibial fractures alone, and in high-risk patient populations (open fractures, GSW tibial fractures). However, the effectiveness of these methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to perform a robust analysis of this population, to include outcomes measures of function and complications. With much of the limited existing literature on tibial nails being in very defined populations, without a strong comparison group there is no clear guidance on when the use of a micromotion device is indicated. Our approach to randomize our patients will reduce the bias that exists in the current literature and provide a robust spectrum of injuries to sub analyze and compare. Objectives Primary Objective Compare post-operative union rates in tibial shaft patients treated with 2 types of intramedullary rod fixation devices. Secondary Objective(s) Compare complication rates, patient reported outcomes, range of motion, pain and radiographic/sonographic outcomes in patients treated with tibial nails.

Participants needed: 372
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of ChicagoUpdated: Oct 9, 2025Locations: 1
Eligibility criteria

Age 18 or older [+1]

Patients not meeting inclusion criteria (Stable fracture patterns) [+10]

Status: Not yet recruiting

Blood Flow Restriction Therapy to Optimize Muscle Size and Strength in Recovery From Lower Limb Fractures

This study will assess the feasibility and effectiveness of blood flow restriction therapy in patients with tibia fractures (or lower leg bone). Personalized blood flow restriction therapy has shown to help people regain muscle size and strength after surgical treatment by allowing them to be able to start physiotherapy on their injured leg sooner. This study aims to evaluate the feasibility and effectiveness of personalized blood flow restriction therapy to improve thigh muscle size and strength in patients with lower limb tibia fractures which require a period of non-weightbearing.

Participants needed: 20
Trial details
Age: 19-60Biological sex: AllType: InterventionalSponsor: University of British ColumbiaUpdated: Aug 5, 2025Locations: 1
Eligibility criteria

Patients aged 19-60 who have sustained an isolated (single bone/area as per AO/O... [+3]

Patients who have sustained multiple fractures in the same limb (i.e. AO/OTA 3 a... [+10]